Vnitr Lek 2012, 58(6):434-438

Catheter ablation of atrio-ventricular accessory pathways in the era of ablation therapy of complex arrhythmias: a changing perspective for oncoming generation of electrophysiologists

M. Fiala*, J. Chovančík, D. Wojnarová, H. Szymeczek, J. Pindor, V. Bulková, R. Neuwirth, O. Jiravský, D. Vavřík, Š. Krawiec, J. Januška
Oddělení kardiologie Nemocnice Podlesí, a. s., Třinec, přednosta prim. MUDr. Marian Branny

Introduction:
Catheter ablation of atrio-ventricular accessory pathways has become a routine treatment method. However, its perspective has been changing in the era of ablation of complex arrhythmias. This study was aimed at evaluating accessory pathways ablation efficacy within the last nine years at one center.

Methods:
From February 2002 to June 2011, catheter ablation of accessory pathways was performed in 247 patients (100 females, 42 ± 16 years). Elimination of accessory pathways conduction in both directions was the procedure endpoint.

Results:
Immediate accessory pathways conduction elimination at the first ablation was achieved in 228 (92%) patients. Ablation failed to eliminate accessory pathways conduction in 19 (8%) patients, or accessory pathways conduction subsequently recurred in another 7 (3%) patients. Repeat ablation was completed in 20 (8%) patients, 2 patients underwent a third ablation procedure. In total, accessory pathway was permanently eliminated in 238 (96%) patients. Ablation failure was connected with a risky position in the vicinity of atrio-ventricular conduction system in 6 (67 %) out of 9 patients. By the individual A, B, C, D operators' experience, efficacy of the first procedure/total efficacy, was 97%/99%, 90%/96%, 87%/87%, and 91%/91%, respectively (comparison of inter-operator efficacy of the first and repeat ablation by Kruskal-Wallis ANOVA test: p = 0,19 and 0,05, respectively).

Conclusion:
Accessory pathways ablation efficacy exceeds 95%, and ablation failure is dominantly related to the accessory pathways location close to the atrio-ventricular conduction system. Individual operator's experience was associated with a certain disparity between high and nearly absolute accessory pathways ablation efficacy.

Keywords: catheter ablation; accessory pathways; outcomes

Received: December 1, 2011; Accepted: March 27, 2012; Published: June 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Fiala M, Chovančík J, Wojnarová D, Szymeczek H, Pindor J, Bulková V, et al.. Catheter ablation of atrio-ventricular accessory pathways in the era of ablation therapy of complex arrhythmias: a changing perspective for oncoming generation of electrophysiologists. Vnitr Lek. 2012;58(6):434-438.
Download citation

References

  1. Dagres N, Clague JR, Kottkamp H et al. Radiofrequency catheter ablation of accessory pathways: Outcome and use of antiarrhythmic drugs during follow-up. Eur Heart J 1999; 20: 1826-1832. Go to original source... Go to PubMed...
  2. Calkins H, Yong P, Miller JM et al. Catheter ablation of accessory pathways, atrioventricular nodal reentrant tachycardia, and the atrioventricular junction: Final results of a prospective, multicenter clinical trial. The Atakr Multicenter Investigators Group. Circulation 1999; 99: 262-270. Go to original source... Go to PubMed...
  3. Kay GN, Epstein AE, Dailey SM et al. Role of radiofrequency ablation in the management of supraventricular arrhythmias. Experience in 760 consecutive patients. J Cardiovascular Electrophysiol 1993; 4: 371-389. Go to original source... Go to PubMed...
  4. Kobza R, Kottakmp H, Piorkowski C et al. Radiofrequency ablation of accessory pathways: contemporary success rate and complications in 323 patients. Z Kardiol 2005; 94: 193-199. Go to original source... Go to PubMed...
  5. Cosío FG, Anderson RH, Kuck KH et al. Living anatomy of the atrioventricular junctions: A guide to electrophysiologic mapping. A Consensus Statement from the Cardiac Nomenclature Study Group, Working Group of Arrhythmias, European Society of Cardiology, and the Task Force on Cardiac Nomenclature from NASPE. Circulation 1999; 100: e31-e37. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.